WHO recommends, often in combination with vaccination or vitamin A [6] . In 2010, for example, WHO reported that 37% of preschool children at risk for STH received treatment, compared to 28% of school-age children [8] . Women of childbearing age typically have higher intensity hookworm infection than schoolage children and are particularly vulnerable to its associated anemia [11] . They are relatively neglected by STH control programs, although millions have received the deworming benefits of albendazole through the Global Programme to Eliminate Lymphatic Filariasis [12] . For the STH program manager, providing preventive chemotherapy to all three risk groups can be logistically and administratively complex. Drugs must be secured from different sources and delivered both through the schools and through different divisions of the health care system. This can require considerable savvy and inter-organizational cooperation.
Third, as the epidemiologic models of Anderson and colleagues indicate [1] , even under the best of circumstances, treatment of school-age children alone is unlikely to have any lasting effect on transmission, especially for hookworm. Recrudescence of STH to pre-treatment levels is generally observed within a few years after treatment ends [13] . Without improvements in WASH to decrease transmission over the long term, regular deworming must be continued in perpetuity to achieve morbidity reduction goals. Thus, the study by Anderson and colleagues invites the loosely-knit STH control community into a conversation. What does ''elimination of STH as a public health problem,'' as articulated in WHA 54.19, require between now and 2020? Are the intended beneficiaries primarily school-age children, or rather, all persons at risk of STH-related morbidity? Is STH control more correctly viewed as a component of school health or as an initiative to reduce STH morbidity and transmission in the community? Is increasing coverage in school-age children a critical first step toward comprehensive STH control or an end in itself?
with preventive chemotherapy, have shifted from morbidity control to the more ambitious interruption of transmission, at least at a regional level [14] . These shifts in emphasis were preceded by careful deliberation and much debate. Reducing transmission in the community is one of the aims of preventive chemotherapy for STH [8] , yet the analysis by Anderson and colleagues indicates that the primary strategy, scaling up preventive chemotherapy coverage among school-age children, is unlikely, by itself, to realize this aim. Is it possible to maintain focus on the critically important need of scaling up treatment in schoolage children while expanding our peripheral vision to include other risk groups and to implement social and environmental interventions that reduce transmission?
In addition to preventive chemotherapy, WHA 54.19 urges member states to ''promote access to safe water, sanitation and health education through intersectoral collaboration.'' Even in the absence of preventive chemotherapy, sanitation may reduce prevalence and intensity of STH infection by approximately 50% [15] . Little is known about what combinations of drug coverage and WASH are required to realize a given impact on transmission. Validating relevant indicators for WASH and modeling the combined effects of WASH and preventive chemotherapy are important areas for further research.
Anderson and colleagues demonstrate the power of epidemiologic modeling to raise critical questions and sharpen our thinking. The key log that they reveal is the need for clarity of purpose and renewed commitment to the promise of WHA 54.19. From a clear, shared vision of elimination of STH as a public health problem, our strategies, objectives, and programs will naturally flow.
